BLK vs CTOR · P/E 27, rev $24.22B vs $105.2M cap
BlackRock Inc (BLK) versus Citius Oncology, Inc. (CTOR) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
CTOR does not have a complete income-statement cache yet.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. CTOR currently screens at market cap $105.2M.
Not investment advice. Open the BLK and CTOR stock pages for the full models.
Not investment advice.